Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1245-1251

  Ng, Chi Fai ^a   Chiu, Peter K F ^a   Li, Miu Ling ^b   Man, Chi Wai ^b   Hou, Simon S M ^a   Chan, Eddie S Y ^a   Chu, Peggy S K ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Bladder augmentation; Complications; Enterocystoplasty; Ketamine cystitis; Overactive bladder

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CREATININE; KETAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BLADDER AUGMENTATION; BLADDER BIOPSY; BLADDER CAPACITY; BLADDER CONTRACTURE; BLADDER DISEASE; BLADDER RECONSTRUCTION; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYSTITIS; CYSTOSCOPY; DETERIORATION; DRUG ABUSE; DYSURIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYDRONEPHROSIS; INTERMITTENT CATHETERIZATION; LAPAROSCOPIC SURGERY; MALE; NOCTURIA; OPERATION DURATION; OVERACTIVE BLADDER; PELVIC PAIN; SEPSIS; URETER STRICTURE; URINARY FREQUENCY; URINARY URGENCY; VESICOURETERAL REFLUX;

ADULT; CONTRACTURE; CREATININE; FEMALE; HUMANS; KETAMINE; MALE; RENAL INSUFFICIENCY; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; URINARY BLADDER; URINATION DISORDERS; YOUNG ADULT;

EID: 84887127185     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0501-4     Document Type: Article

References (20)

1. Kalsi SS, Wood DM, Dargan PI (2011) The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 4:7107-7116
2. Wolff K (2012) Ketamine. In: Verster JC et al (eds) Drug abuse and addiction in medical illness: causes, consequences and treatment. Springer, New York, pp 201-211
3. Froster JA, Harrison SCW (2012) Ketamine uropathy: rising to the challenges of a new condition. BJU Int 109:1277-1278
4. Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110:1762-1766
5. Lin M (2004) The underappreciated dangers of "club drugs": what clinicians need to know. Adv Stud Med 4:191-198
6. Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69:810-812
7. Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, Tse ML, Lau FL (2007) 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311-313
8. Middela S, Pearce I (2011) Ketamine-induced vesiculopathy: a literature review. Int J Clin Pract 65:27-30
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470
10. Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JML, Lau FL, Yiu MK, Man CW (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616-1622
11. Biers SM, Venn SN, Greenwell TJ (2012) The past, present and future of augmentation cystoplasty. BJU Int 109:1280-1293
12. Stein R, Schröder A, Thüroff JW (2012) Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations. J Pediatr Urol 8:153-161
13. Stein R, Kamal MM, Rubenwolf P, Ziesel C, Schröder A, Thüroff JW (2012) Bladder augmentation using bowel segments (enterocystoplasty). BJU Int 110:1078-1094
14. Craven R (2007) Ketamine. Anaesthesia 62(Suppl 1):48-53
15. Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376-382
16. Blonk MI, Koder BG, van den Bemt PM, Huygen FJ (2010) Use of oral ketamine in chronic pain management: a review. Eur J Pain 14:466-472
17. Greenwell TJ, Venn SN, Mundy AR (2001) Augmentation cystoplasty. BJU Int 88:511-525
18. DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101-2107
19. Tabor PA, Lopez DA (2004) Comply with us: improving medication adherence. J Pharm Pract 17:167-180
20. Lucas GM (2011) Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sci 88:948-952